Clinical Trials Browser

Unknown × Mesothelioma, Malignant × Nivolumab × Clear all

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT04013334 2022-06-16

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Phase 2 Unknown

12 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

Clinical Trials

Immunological Variables Associated to ICI Toxicity in Cancer Patients

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma